{"cited_by_count":991031,"description":"This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia.","display_name":"Acute Lymphoblastic Leukemia research","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T10950","wikipedia":"https://en.wikipedia.org/wiki/Acute_lymphoblastic_leukemia"},"field_id":"27","id":"T10950","keywords":[{"display_name":"acute lymphoblastic leukemia","id":"acute-lymphoblastic-leukemia","score":0.3881,"url":"https://openalex.org/keywords/acute-lymphoblastic-leukemia"},{"display_name":"pediatric leukemia","id":"pediatric-leukemia","score":0.4694,"url":"https://openalex.org/keywords/pediatric-leukemia"},{"display_name":"childhood acute lymphoblastic leukemia","id":"childhood-acute-lymphoblastic-leukemia","score":0.7434,"url":"https://openalex.org/keywords/childhood-acute-lymphoblastic-leukemia"},{"display_name":"T-cell acute lymphoblastic leukemia","id":"t-cell-acute-lymphoblastic-leukemia","score":0.5783,"url":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia"},{"display_name":"minimal residual disease","id":"measurable-residual-disease","score":0.2409,"url":"https://openalex.org/keywords/measurable-residual-disease"},{"display_name":"B-cell acute lymphoblastic leukemia","id":"b-cell-acute-lymphoblastic-leukemia","score":0.5498,"url":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia"},{"display_name":"B-cell precursor acute lymphoblastic leukemia","id":"b-cell-precursor-acute-lymphoblastic-leukemia","score":0.7696,"url":"https://openalex.org/keywords/b-cell-precursor-acute-lymphoblastic-leukemia"},{"display_name":"adult acute lymphoblastic leukemia","id":"adult-acute-lymphoblastic-leukemia","score":0.8825,"url":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia"},{"display_name":"L-asparaginase","id":"l-asparaginase","score":0.2163,"url":"https://openalex.org/keywords/l-asparaginase"},{"display_name":"blinatumomab","id":"blinatumomab","score":0.6472,"url":"https://openalex.org/keywords/blinatumomab"},{"display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","id":"philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","score":0.5087,"url":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia"},{"display_name":"MLL rearrangement","id":"mll-rearrangement","score":0.3666,"url":"https://openalex.org/keywords/mll-rearrangement"},{"display_name":"leukemia relapse","id":"leukemia-relapse","score":0.2214,"url":"https://openalex.org/keywords/leukemia-relapse"},{"display_name":"central nervous system relapse","id":"cns-relapse","score":0.334,"url":"https://openalex.org/keywords/cns-relapse"},{"display_name":"childhood acute leukemia","id":"childhood-acute-leukemia","score":0.489,"url":"https://openalex.org/keywords/childhood-acute-leukemia"},{"display_name":"CNS prophylaxis","id":"cns-prophylaxis","score":0.4341,"url":"https://openalex.org/keywords/cns-prophylaxis"},{"display_name":"BCR-ABL1","id":"bcr-abl1","score":0.2011,"url":"https://openalex.org/keywords/bcr-abl1"},{"display_name":"adult leukemia","id":"adult-leukemia","score":0.3993,"url":"https://openalex.org/keywords/adult-leukemia"},{"display_name":"hyperdiploidy","id":"hyperdiploidy","score":0.2876,"url":"https://openalex.org/keywords/hyperdiploidy"},{"display_name":"ETV6-RUNX1","id":"etv6-runx1","score":0.8611,"url":"https://openalex.org/keywords/etv6-runx1"},{"display_name":"inotuzumab ozogamicin","id":"inotuzumab-ozogamicin","score":0.6821,"url":"https://openalex.org/keywords/inotuzumab-ozogamicin"},{"display_name":"relapsed/refractory leukemia","id":"relapsed-refractory-leukemia","score":0.2965,"url":"https://openalex.org/keywords/relapsed-refractory-leukemia"},{"display_name":"relapsed leukemia","id":"relapsed-leukemia","score":0.3058,"url":"https://openalex.org/keywords/relapsed-leukemia"},{"display_name":"IKZF1","id":"ikzf1","score":0.3446,"url":"https://openalex.org/keywords/ikzf1"},{"display_name":"intrathecal methotrexate","id":"intrathecal-methotrexate","score":0.347,"url":"https://openalex.org/keywords/intrathecal-methotrexate"}],"legacy_keywords":["Childhood Cancer","Acute Lymphoblastic Leukemia","Genetic Alterations","Treatment Outcome","Minimal Residual Disease","Pharmacogenomics","Prognostic Factors","Thiopurine Therapy","Relapse Risk","Pediatric Oncology"],"openalex_id":"https://openalex.org/T10950","source_created_date":"2024-01-23T15:27:08","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2739","url":"/topics/T10950","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10950","works_count":72282,"label":"Acute Lymphoblastic Leukemia research","provider":"openalex","revision":"f7cfad76985f33be","taxonomy_revision":"f050b5d4780b1289","title":"Acute Lymphoblastic Leukemia research","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36240731245259238","address_version":"morton4x16-v1","coordinates":[4,27,2739,10950],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}